14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $6.10 $80.02 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Nov 04, 2016 $129.00 $129.00 $129.00 $129.00 11 384 500
Nov 03, 2016 $127.52 $127.52 $127.52 $127.52 1 917 000
Nov 02, 2016 $127.74 $127.74 $127.74 $127.74 1 786 700
Nov 01, 2016 $131.42 $131.42 $131.42 $131.42 1 907 100
Oct 31, 2016 $130.50 $130.50 $130.50 $130.50 2 284 800
Oct 28, 2016 $135.59 $135.59 $135.59 $135.59 3 247 700
Oct 27, 2016 $131.37 $131.37 $131.37 $131.37 4 449 000
Oct 26, 2016 $121.59 $121.59 $121.59 $121.59 3 834 200
Oct 25, 2016 $121.41 $121.41 $121.41 $121.41 931 900
Oct 24, 2016 $121.61 $121.61 $121.61 $121.61 1 297 900
Oct 21, 2016 $120.26 $120.26 $120.26 $120.26 1 111 300
Oct 20, 2016 $122.47 $122.47 $122.47 $122.47 882 900
Oct 19, 2016 $120.31 $120.31 $120.31 $120.31 967 800
Oct 18, 2016 $121.34 $121.34 $121.34 $121.34 1 130 200
Oct 17, 2016 $119.47 $119.47 $119.47 $119.47 1 241 400
Oct 14, 2016 $118.34 $118.34 $118.34 $118.34 958 000
Oct 13, 2016 $119.61 $119.61 $119.61 $119.61 1 151 900
Oct 12, 2016 $118.75 $118.75 $118.75 $118.75 1 323 300
Oct 11, 2016 $121.77 $121.77 $121.77 $121.77 1 450 200
Oct 10, 2016 $126.05 $126.05 $126.05 $126.05 923 600
Oct 07, 2016 $125.05 $125.05 $125.05 $125.05 1 024 900
Oct 06, 2016 $122.89 $122.89 $122.89 $122.89 951 300
Oct 05, 2016 $125.51 $125.51 $125.51 $125.51 1 058 600
Oct 04, 2016 $123.41 $123.41 $123.41 $123.41 1 277 100
Oct 03, 2016 $122.14 $122.14 $122.14 $122.14 1 484 700
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT